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Abstract
A crucial step in the development of muscle cells in all metazoan animals is the assembly and anchorage of the sarcomere,
the essential repeat unit responsible for muscle contraction. In Caenorhabditis elegans, many of the critical proteins involved
in this process have been uncovered through mutational screens focusing on uncoordinated movement and embryonic
arrest phenotypes. We propose that additional sarcomeric proteins exist for which there is a less severe, or entirely different,
mutant phenotype produced in their absence. We have used Serial Analysis of Gene Expression (SAGE) to generate a
comprehensive profile of late embryonic muscle gene expression. We generated two replicate long SAGE libraries for sorted
embryonic muscle cells, identifying 7,974 protein-coding genes. A refined list of 3,577 genes expressed in muscle cells was
compiled from the overlap between our SAGE data and available microarray data. Using the genes in our refined list, we
have performed two separate RNA interference (RNAi) screens to identify novel genes that play a role in sarcomere
assembly and/or maintenance in either embryonic or adult muscle. To identify muscle defects in embryos, we screened
specifically for the Pat embryonic arrest phenotype. To visualize muscle defects in adult animals, we fed dsRNA to worms
producing a GFP-tagged myosin protein, thus allowing us to analyze their myofilament organization under gene
knockdown conditions using fluorescence microscopy. By eliminating or severely reducing the expression of 3,300 genes
using RNAi, we identified 122 genes necessary for proper myofilament organization, 108 of which are genes without a
previously characterized role in muscle. Many of the genes affecting sarcomere integrity have human homologs for which
little or nothing is known.
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Introduction
Muscle tissue is important for humans in a myriad of processes
including movement, digestion, and the pumping of blood through
the cardiovascular system. Afflictions that affect muscle can be
debilitating in any of these processes. The underlying cause of
many myopathies lies within the cells that make up muscle tissue.
Specifically, defects in components of the functional repeat unit of
muscle, the sarcomere, are implicated in over 20 diseases [1]. The
nematode Caenorhabditis elegans is a valuable model organism for the
study of muscle due to the similarity of worm body wall muscle to
vertebrate muscle, along with its semi-transparent cuticle that
allows for visualization of muscle structures in vivo. The basic
protein components within a C. elegans sarcomere have vertebrate
counterparts, with only minor differences in protein composition
and organization [2–4]. Much of the work focused on sarcomere
assembly is restricted to muscle cells that contain multiple
sarcomeres and make up body wall muscle in C. elegans. Building
a functional sarcomere in C. elegans is a complex process that
requires the assembly of two main attachment complexes, the M-
line and dense body. Both of these structures are anchored in the
sarcolemma, projecting inwards to allow for anchoring of actin
filaments in the case of dense bodies, or myosin filaments in the
case of the M-line. This anchorage is necessary to transmit the
force created from the contraction of myofibrils to the muscle cell
basement membrane [2,5]. Many of the proteins needed to form a
functional sarcomere in the worm are homologs of proteins
required in vertebrate focal adhesion complexes [3]. Adhesion
complexes are found in migrating cells involved in a number of
processes including tissue repair, immune responses, and tumor
formation [6].
Much of what we know about the protein composition of
adhesion complexes in C. elegans muscle was uncovered via
mutational screens. Uncoordinated movement (Unc) and Para-
lyzed and Arrested at Two-fold stage (embryonic arrest, Pat) are
the two primary phenotypes used to identify muscle mutants in the
PLoS Genetics | www.plosgenetics.org 1 June 2009 | Volume 5 | Issue 6 | e1000537worm. An Unc phenotype can be caused by a defect in muscle
cells, the neural architecture or neuronal function which triggers
their contraction. The Pat phenotype is more severe and appears
to be primarily muscle specific in nature, as almost all Pat mutants
identified by Williams and Waterston (1994) [7] have since been
shown to be components of the attachment complex or associated
with the basement membrane. All of the proteins linked to this
phenotype are essential for the initial assembly of the sarcomere
and/or involved in the attachment of muscle cells to the basement
membrane [7,8], including UNC-52/perlecan [9], PAT-3/b-
integrin [10], PAT-4/ILK [11] and DEB-1/vinculin [12]. Proper
muscle function, attachment to the basement membrane and
communication with the underlying hypodermis are critical for
elongation of embryos beyond the two-fold stage [7]. Interestingly,
less severe mutations in some Pat genes lead to an Unc phenotype
due to partial function of the protein. The unc-89, unc-95 and unc-
98 genes also encode proteins found in the attachment structures
that anchor the myofilament lattice [13–15]; however, loss of their
gene products is associated with an Unc, rather than a Pat,
phenotype. Animals homozygous for null mutations of another
gene class, the Dim (disorganized muscle) mutants, exhibit a far
less acute phenotype. These animals are wild type in appearance
and movement, but display minor muscle defects upon close
observation [16].
The work done in C. elegans first demonstrated the important
role of the basement membrane protein UNC-52/perlecan in the
initial assembly of adhesion structure in the muscle cell membrane
[8,9,17] as well as the key role of the UNC-112 protein and, by
inference, its human orthologs Kindlin-1,2,3 in the assembly of
integrin-containing attachment complexes [18,19]. Furthermore,
studies on flies and worms demonstrate that ILK is an adaptor
molecule and all of its behavior in regards to muscle attachment
can be explained as an adaptor molecule, not as a kinase
[11,20,21]. The many studies of adhesion receptors that have been
done over the years have led to the idea that adhesion complexes
are platforms where many molecules meet to organize the
cytoskeleton and trigger signalling. Recent studies highlight the
striking similarity between vertebrate focal adhesion plaques and
C. elegans muscle adhesion structures and position integrin linked
kinase, as well as FERM and LIM domain proteins as central
players at focal adhesions [3,22].
In humans, mutations in several sarcomeric and sarcolemmal
proteins have been shown to cause muscular dystrophy and
cardiomyopathies (reviewed in [23]). For example, loss of Kindlin-
1, an actin-ECM linker protein first described in C. elegans as
UNC-112 [18], causes Kindler syndrome, characterized by
neonatal blistering, sun sensitivity, muscle atrophy, abnormal
pigmentation, and fragility of the skin [24]. Clearly, an
understanding of muscle development and function is an
important step towards the development of treatments for
muscle-related disease.
To date, mutational screens for genes affecting C. elegans body
wall muscle have identified about 70 genes. Recent studies using
DNA microarray technology have identified thousands of
transcripts that are made in muscle cells. Using this method of
transcriptional profiling Roy et al. [25] were able to identify 1,364
genes enriched in the body wall muscle of L1 larvae, and Fox et al.
[26] were able to identify 5,710 genes expressed in embryonic
body wall muscle. Another method of identifying large numbers of
transcripts from isolated tissue specific RNA is Serial Analysis of
Gene Expression or SAGE [27]. This technology differs from gene
chip technology because it allows the identification of all
transcripts including those not previously identified by analysis
of the sequenced genome. Here, we use this technology to identify
over 7,900 genes that are potentially expressed in embryonic
muscle cells. Several large-scale transcriptional profiling screens
using DNA microarray technology and more recently RNA-Seq
have been done on various mouse and human tissues and cell lines
including muscle [28–30]. In this study we describe the first SAGE
gene expression profile done on muscle tissue in C. elegans.
In addition to generating a list of genes expressed in embryonic
muscle cells, we have carried out two RNAi screens designed to
identify muscle-affecting genes in C. elegans. Screening was
performed using a subset of about 3,600 genes that were found
to be expressed in muscle using both SAGE and microarray
analysis [26] and thus have a high probability of being expressed
in body wall muscle. In order to find as many muscle affecting
genes as possible, our screens were designed to identify
myofilament-affected animals, regardless of whether the worms
exhibited a visible phenotype or appeared wild type. We have
identified 122 genes involved in proper myofilament organization,
108 of which had no previously characterized role in muscle
structure or function.
Results
An embryonic-muscle transcriptome for Caenorhabditis
elegans
The C. elegans embryo has a total of 123 muscle cells, the
majority of which (81) are body wall muscle cells [31]. The myo-3
gene encodes a myosin heavy chain protein which is the central
component of body wall muscle thick filaments and is present in at
least 85 embryonic muscle cells [32]. Myosin protein expression is
first detected during mid embryogenesis. Tagging MYO-3 with
GFP and expressing it under the control of its own promoter is
therefore an excellent way of identifying muscle cells prior to and
during early myofilament formation using GFP fluorescence [33]
(see Figure 1A and 1B).
We have used a strain expressing a GFP-tagged MYO-3 protein
[34] to obtain a relatively purified population of embryonic muscle
cells after Fluorescence Activated Cell Sorting (FACS). Whole
embryos were manually disrupted to obtain a suspension of mostly
single cells that was then passed through a FACS machine to
Author Summary
Muscular diseases affect many people worldwide. While
we have learned much about the sarcomere, the basic
building block of muscle cells, there are still numerous
questions that remain to be answered. We must learn
more about proteins expressed in muscle and how they
interact so that better treatments for myopathies can be
developed. The nematode Caenorhabditis elegans is a
valuable model organism for the study of muscle due to
similarities between worm body wall muscle and verte-
brate muscle, along with its semi-transparent cuticle that
allows for visualization of muscle structures in live animals.
We have used transcriptional profiling methods to identify
the majority of genes that are expressed in the embryonic
body wall muscle cells of C. elegans. To gain insight into
possible functions performed by these genes and their
corresponding proteins, we examined animals and muscle
cells for abnormalities after the targeted inactivation of
about 3,300 genes. We identified 122 genes necessary for
proper myofilament organization, 108 of which had no
previously characterized role in muscle. This approach
proved to be a rapid and sensitive means to identify genes
that affect muscle differentiation and sarcomere assembly.
Exploring the C. elegans Muscle Transcriptome
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we obtained a range of 90% to 95% GFP expressing cells at the
final step. Only samples that consisted of at least 90% fluorescing
MYO-3::GFP live cells were used for RNA extraction.
We have constructed two Long SAGE biological replicate
libraries using RNA isolated from our FAC-sorted embryonic
muscle cells (data available at http://elegans.bcgsc.bc.ca). A total
of 49,655 and 120,825 sequenced tags were obtained from the
SWEM1 and SW031 libraries, respectively. We used a sequence
quality filter of 0.99 to reduce the number of tags incorrectly
assigned due to sequencing errors. This gave us adjusted tag
numbers for the two libraries of 33,827 and 89,561, respectively
and these numbers were used for all subsequent analyses. By
combining the data from both libraries we identified 10,724
unique sequence tags representing 7,974 genes expressed in
embryonic muscle cells. Despite the difference in sampling size
between these two libraries almost 88% of the genes identified are
present in both SWEM1 and SW031. In addition, the correlation
coefficient of tag counts observed for genes found in the two
libraries is 0.94, indicating that variability between these samples is
low (Figure 2). This result is comparable to the correlation
coefficient observed for Affymetrix GeneChip biological replicates
(see for example [26]).
Not all of the 7,974 genes we identified in the embryonic muscle
libraries are necessarily specific to muscle, or even enriched in
muscle. To gain some insight into these facets of expression we
compared the results from the embryonic muscle libraries to those
obtained from libraries using RNA isolated from purified
embryonic intestinal cells (SWEG1) or pan neuronal cells
(SW028) (Figure 3A, [35]; data available at http://elegans.bcgsc.
bc.ca). We found that more than half of the muscle-expressed
genes (4,315) are also present in both the intestinal and pan
neuronal libraries, while about 15% of the genes (1,294) we
detected are candidates for unique expression within muscle
(Dataset S1). The remaining 2,365 genes are expressed in either
neurons or the intestine in addition to muscle. Similar percentages
of overlapping gene expression were observed for the other two
tissues as well.
To identify genes with enriched expression in muscle we
compared the relative abundance of sequence tags for a particular
gene in the muscle libraries to the number of tags for the same
gene in the whole-embryo SAGE library SWN22. A total of
192,661 sequence tags were obtained for the SWN22 library.
Within this data set, there are 133,862 tags that pass the 0.99
sequence quality threshold representing 12,165 unique tag species
and 9,064 genes (data available at http://elegans.bcgsc.bc.ca).
Sequence tags for 6,984 of the muscle-expressed genes are also
present in the whole embryo library. We used fold-change and a
minimal tag count filter to determine enrichment. Depending on
the fold-change cut-off that was used we observed between 1,459
(1.7 fold-change) and 228 (5.0 fold-change) genes enriched for
expression in muscle (Dataset S2).
A refined muscle transcriptome
Several different approaches have been taken to identify genes
that are expressed in muscle cells. These include a genetic
Figure 1. GFP-tagged embryonic muscle cells purified by FACS. MYO-3::GFP expression in the body wall muscle cells of an RW1596 embryo
(A,B), and in purified embryonic muscle cells after isolation and FAC sorting (C,D) visualized by Fluorescence microscopy (A,C) and DIC microscopy
(B,D). Final fluorescence intensity scatter plot of wild-type (non-GFP) cells (E) and MYO-3::GFP positive cells (F). Cells in box P3 were sorted as GFP
positive.
doi:10.1371/journal.pgen.1000537.g001
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muscle, determining the cell expression patterns of proteins using
antibodies or promoter GFP fusions, and identifying the
transcripts present in isolated muscle cells by SAGE, GeneChip
or rtPCR or cDNA analysis. Here we determine that the majority
of the muscle genes identified by these other methods is present in
our SAGE transcriptome.
Previous genetic analyses have identified about 70 genes that,
when mutated, affect muscle structure or function in some way.
Sixty-four of these known muscle-affecting genes are included in
the 7,974 genes that define our muscle transcriptome (Dataset S3).
Some muscle affecting genes that were not found in the muscle
transcriptome encode proteins that are expressed in the hypoder-
mis (vab-19 and mua-1) or in neurons (ace-2) and not muscle [36–
38], while others like unc-22 are expressed in muscle cells but just
not during embryogenesis [39]. A large-scale project involving the
mapping of cell expression patterns of promoter GFP fusions has
identified 587 genes that are expressed in muscle; data available at
http://www.wormatlas.org/). We have determined that 452 of
these genes (,77%) are present in at least one of the two SAGE
embryonic muscle libraries (Dataset S4). Interestingly, GFP
expression in body wall muscle cells was observed for 39 genes
that were represented by only a single SAGE tag and 167 genes
that were represented by fewer than 5 SAGE tags in either SAGE
library.
We also compared the muscle transcriptome generated by
SAGE to one generated using an alternative gene expression
analysis platform, the Affymetrix GeneChip [26]. The GeneChip
study is comparable to our study as the analysis was also done
using RNA isolated from FAC sorted embryonic muscle cells. The
Fox et al (2007) study [26] identified 5,170 different transcripts in
freshly sorted embryonic muscle cells after direct isolation at ‘0’
hours. A comprehensive list of 9,567 genes can be obtained by
combining the SAGE and Affymetrix data; however, only 3,577
(37%) of these genes overlap the two data sets (Figure 3B; Dataset
S5). As might be expected more highly expressed genes are more
likely to be detected by both platforms. The mean sequence tag
count for the genes detected by both SAGE and Affymetrix
GeneChips is 19 tags per 100,000, but only 6 tags per 100,000 for
the genes whose expression is detected by SAGE only. Similarly,
the median sequence tag counts are 6 tags per 100,000 and 3 tags
per 100,000, respectively. The moderate correlation (0.77) of
SAGE sequence tag counts per gene and Affymetrix signal
intensities for the 3,577 genes determined to be ‘present’ in both
the SAGE and Affymetrix GeneChip data is consistent with
previously published comparisons between SAGE and Affymetrix
GeneChips [40].
Partially because of the large dynamic range of individual gene
expression, (i.e. three orders of magnitude in our study) low
abundance messages are a problem for all expression platforms to
Figure 2. Reproducibility of SAGE biological replicate libraries. Comparison of two Long SAGE biological replicate libraries for embryonic
muscle cells in C. elegans (SW031 and SWEM1). A total of 88% of the sequence tags are similarly expressed with a correlation coefficient of 0.94.
DiscoverySpace was used to generate the plot [68].
doi:10.1371/journal.pgen.1000537.g002
Exploring the C. elegans Muscle Transcriptome
PLoS Genetics | www.plosgenetics.org 4 June 2009 | Volume 5 | Issue 6 | e1000537detect. They simply get swamped out by the more abundantly
transcribed messages and are often lost during the stochastic
process of sampling the RNA populations. For our SAGE studies
we define a transcript as ‘present’ if it is represented by at least one
sequence tag, even though there is some controversy as to whether
singletons (i.e. single sequence tags representing a gene) are a
reliable measure of gene activity [40]. The majority of the 4,397
genes that were identified in our SAGE study, but that were not
identified in the Afffymetrix GeneChip study are low abundance
transcripts with an average sequence tag count of 6 per 100,000.
Before initiating a functional study of the muscle transcriptome
we felt it prudent to refine the transcriptome and only study genes
with a high probability of actually being expressed in muscle cells.
We have generated a refined embryonic-muscle transcriptome
consisting of the 3,577 genes that are present in at least one of the
two SAGE libraries and also in the GeneChip library generated by
Fox et al, 2007 [26] (Figure 3B, Dataset S5).
RNAi analysis of the muscle transcriptome identifies
genes involved with sarcomere assembly and
maintenance
Our refined embryonic-muscle transcriptome identified 3,577
genes that are expressed in muscle cells. A small number of these
genes have been studied in great detail and much is known about
their role in a functioning muscle cell (reviewed in [3]). However,
little or nothing is known about the function and/or relevance to
muscle development of the majority of the genes identified by
transcriptional profiling. Gene inactivation or knockdown by
RNAi has been used successfully to screen much of the C. elegans
genome and possible functions have been suggested for some genes
[41–43]. Rather than simply repeat previously performed RNAi
screens, we have designed two muscle specific RNAi screens, one
to identify genes essential for embryonic muscle formation, and
another to identify novel genes involved in myofilament assembly.
Both screens utilized the RNAi feeding library constructed by the
Ahringer lab [42]. For various reasons we were not able to obtain
double stranded RNA for all 3,577 genes in our muscle
transcriptome, screening 85 and 92% of the genes respectively.
The purpose of our first RNAi screen was to identify genes
essential for embryonic muscle formation. Previous work by
Williams and Waterston (1994) [7] has shown that animals lacking
functional muscle exhibit a similar embryonic arrest phenotype
designated the Pat phenotype. To date, 19 genes that affect muscle
have been shown to produce this phenotype when mutated [7,9–
12,17,44–51]. Here we utilized the approach outlined in Figure 4
pathway A to screen for Pat mutants after RNAi treatment of wild
type animals. Our initial screen of 3,031 genes was done in liquid
culture and identified 371 RNAi treatments resulting in embryonic
lethality, sterility, or movement abnormalities. After eliminating
well characterized and published genes, the remaining 170 positive
Figure 3. Comparison of the embryonic muscle SAGE profile with other tissue-specific SAGE libraries and Affymetrix GeneChip
data. The overlap between genes found in tissue specific SAGE libraries for C. elegans muscle (SWEM1 and SW031), intestinal (SWEG1) and pan
neuronal (SW028) cells are shown in (A). Only 11%–16% of the genes identified are unique for each cell type. (B) Comparison of both muscle SAGE
libraries to previously published Affymetrix GeneChip data [26] on sorted embryonic muscle cells. Less than half (45%) of the 7,974 genes detected by
SAGE were also detected by GeneChip technology.
doi:10.1371/journal.pgen.1000537.g003
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Further analyses revealed that four genes T27B1.2, F31D5.3,
T28B4.3, and F25B3.6 consistently produced Pat animals when
inactivated. We were also able to identify effects on post-
embryonic muscle development by feeding double stranded
RNA to wild type animals after hatching. Adult hermaphrodites
were observed using polarized light microscopy and significantly
disorganized body wall muscle was seen after RNAi treatment for
the genes T27B1.2, F31D5.3, and T28B4.3 (Figure 5), but not
F25B3.6 (data not shown).
The second RNAi screen utilized the approach outlined in
Figure 4 pathway B, and involved screening for defects in myosin
localization, using the MYO-3::GFP expressing strain RW1596
[34]. The GFP-tagged MYO-3 protein in this strain is transcribed
from a modified gene contained on a transgenic array and is the
only myo-3 gene product produced. Loss of the array results in
animals that arrest at the two-fold stage of embryogenesis (the Pat
phenotype). It has been shown previously that RW1596 animals
experience an acute loss of myofilament stability with age [52]. To
avoid false positive results in the screen, we first analyzed
synchronized RW1596 worms from young adults until 3-days of
adulthood for abnormalities in MYO-3::GFP expression. We
found that the percentage of animals displaying myosin defects
increased from 22.8% in the L4/young adult stage to 31.9% in 1-
day old adults, 42.5% in 2-days old adults, and 75% in 3-days old
adult animals. Figure 6 shows the observed myofilament
abnormalities in aging RW1596 animals as visualized by GFP
fluorescence microscopy (Figure 6A–6D) as well as polarized light
microscopy (Figure 6F). This age related myofilament instability
does not become apparent in N2 wild-type animals until much
later (Figure 6G; our unpublished data). Thus, it would appear
that the presence of the GFP-tagged MYO-3 protein renders the
myofilaments more susceptible to perturbation than normal,
providing a sensitized background for the detection of sarcomere
affecting genes. As a result of this analysis, we screened only L4/
young adult animals in the following RNAi experiment.
In a preliminary screen, we examined a total of 3,297 genes for
RNAi-induced myofilament defects (Figure 7A). Briefly, adult
hermaphrodites that had been grown on plates containing RNAi
feeding bacteria were transferred to fresh plates containing the
same bacteria for 24 hrs and then removed. Their progeny were
scored as L4 larvae or young adults. After a brief inspection for
overt phenotypic anomalies, animals were scored for myofilament
defects and then assigned to one of four classes. In order for RNAi-
treated hermaphrodites to be placed in the High class (HC), 75 to
100% of the animals screened had to exhibit some sort of MYO-3
Figure 4. Schematic diagram for the two RNAi by feeding screens. The muscle transcriptome includes 3,297 genes that overlap with the
Ahringer RNAi feeding library, the SAGE dataset and the Affymetrix GeneChip dataset. (A) The protocol used for a high-throughput liquid RNAi
feeding screen to identify genes essential for embryonic muscle formation and (B) the protocol used for an RNAi feeding screen on solid media for
defects in myosin localization using RW1596, a MYO-3::GFP expressing strain. See Materials and Methods for details.
doi:10.1371/journal.pgen.1000537.g004
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wild-type animals treated with the empty RNAi feeding vector L4440 showing nicely organized filament structure (arrow). In animals treated with
dsRNA for T27B1.2 (B), F31D5.3 (C) or T28B4.3 (D), filaments are disorganized and gaps are present in the myofilament (asterisk).
doi:10.1371/journal.pgen.1000537.g005
Figure 6. Sarcopenia in aging nematodes. Synchronized animals were observed for irregularities in filament organization with age using the
GFP-tagged MYO-3 marker strain RW1596. Fluorescence images are shown for L4/young adult (A), 1-day adult (B), 2-day adult (C), and 3-day adult (D)
animals. As the filament structure is nicely organized in L4/young adult animals (arrow), both the severity of myofilament disorganization (asterisk) as
well as the percentage of animals affected increase during aging (E). To preclude any artifacts caused by GFP itself, we visualized disorganized
filaments in 3-day adult RW1596 animals using polarized light (F, asterisk). No defects are visible in 3-day adult N2 animals (G, arrow), indicating an
early onset of sarcopenia in RW1596 muscle filaments.
doi:10.1371/journal.pgen.1000537.g006
Exploring the C. elegans Muscle Transcriptome
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Intermediate (IC), Low (LC) and Wild type (WT) classes were
50 to 75%, 25 to 50% and 0 to 25%, respectively. The majority
of the genes that were tested caused either a Low (1,710) or a
Wild type (1,252) class phenotype when inactivated by RNAi
treatment. We only considered the RNAi treatments resulting in
High or Intermediate phenotypes to be muscle-affecting. To
confirm this data, we repeated the RNAi treatments for the 290
genes that fell in these two categories. In addition, a slightly
modified screen (see Materials and Methods) was used to test the
45 essential genes identified in the primary screen that resulted
in few, if any, adult progeny.
In the re-screen, both the number of analyzed animals and the
scoring stringency were increased to reduce false-positive results.
We required an animal to have myofilament defects in multiple
muscle cells to be deemed affected. After this second round of
screening, we identified a total of 118 genes affecting MYO-
3::GFP localization and/or stability in the RW1596 strain
(Figure 7B). The remaining genes failed to meet the imposed
stringency of the second screen. The clones from the RNAi feeding
library used for each of the 118 positive treatments were verified
by PCR using gene specific primers, or in some cases, sequencing.
Fifty-eight of the 118 genes that affect myosin localization and/or
stability did not display any obvious anatomical or behavioral
Figure 7. Diagram summarizing the results of the RNAi screen for defects in myosin localization. (A) The results of the preliminary screen
were grouped into four classes according to the proportion of animals showing irregularities in myosin localization after RNAi treatment. High class
(HC) for [75–100], intermediate class (IC) for [50–75], low class (LC) for [25–50], and wild-type class (WT) for [0–25] percent affected animals per scoring.
Only genes resulting in IC (248 genes) and HC (42 genes) were considered as ‘‘muscle affecting’’ to be further analyzed in the re-screen. Feeding of 45
different RNAi constructs resulted in embryonic or adult lethality (green); no animals could be scored in the F1 generation and these genes were
included in a modified re-screen (see Materials and Methods for details). (B) Summarized results of re-screening 335 genes identified as muscle
affecting in the preliminary screen. Twelve genes remained in the HC category, 6 of which have been previously reported to affect C. elegans muscle
structure, and 107 genes were scored in the intermediate class, including 7 known muscle-affecting genes. The remaining 216 genes did not reach
the increased stringency and dropped under the 50% cutoff.
doi:10.1371/journal.pgen.1000537.g007
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not have been identified in a conventional screen.
The MYO-3::GFP abnormalities observed have been arranged
into three categories that are described below and in Dataset S6.
In some cases gene inactivation by RNAi resulted in more than
one of these myofilament abnormalities, albeit in different animals.
This could be due to variability in gene knockdown from animal to
animal. Figure 8A and 8B show the phenotypes observed for the
control experiments that were included in this screen. The animal
in Figure 8A was fed bacteria containing an empty L4440 feeding
vector and represents the unaffected state. The MYO-3::GFP
protein is well ordered in the myofilament lattice and there are no
unlocalized clumps of GFP. The animal in Figure 8B was fed
dsRNA for GFP and has a marked reduction in the amount of
MYO-3::GFP protein produced. The most common phenotype
observed after RNAi knockdown is a general disorganization of
the myofilaments, including minor GFP aggregations, that
somewhat resembles the age related sarcopenia observed in older
RW1596 hermaphrodites. Examples of this phenotype are shown
in Figure 8C and 8D. Eighty-two of the genes we tested have been
assigned exclusively to this category (i.e. this was the only
phenotype observed after RNAi knockdown), although most
animals assigned to the two other categories also exhibited this
phenotype in some muscle cells. The two other distinct phenotypes
that we observed are less common. A total of 22 genes have been
assigned to the second category. In muscle cells exhibiting this
phenotype, the MYO-3::GFP containing filaments are well
ordered but small aggregations of GFP appear along the filaments
(shown in Figure 8E and 8F). In many cases large or small gaps in
the lattice are also present indicating that some myofilaments have
detached from the muscle cell membrane. Only 13 genes have
been assigned to the third category. The MYO-3::GFP abnor-
malities in muscle cells exhibiting this phenotype are characterized
by large GFP deposits, and are accompanied by disorganization of
the myofilaments (shown in Figure 8G and 8H). Again large or
small gaps in the lattice may also be present. Only one gene did
not fall exclusively into any one category. Animals fed dsRNA for
the known muscle gene unc-112 displayed myofilament abnormal-
ities consistent with both categories 2 and 3. The other 13 known
muscle genes identified in this screen fall into all three phenotypic
categories; unc-45, uig-1, unc-23, and mup-4 were assigned to
category 1, dim-1, unc-95, and unc-15 were assigned to category 2
and pat-4, pat-6, vab-10, unc-89, act-3, and tnt-3 were assigned to
category 3 (see Dataset S6). All available information about our
screen, including diagnostic images, may be accessed at http://
www.zoology.ubc.ca/,alorch/rnai A subset of 22 genes that
scored positive in the GFP reporter myofilament screen was also
analyzed by RNAi in N2 wild-type animals using polarized light.
The observed phenotypes in body wall muscle range from minor
structural irregularities making it very difficult to visualize
Figure 8. RNAi induced myofilament abnormalities visualized by MYO-3::GFP. Representative fluorescent images are shown for (A) the
empty vector plasmid L4440, resulting in proper wild-type filament organization and (B) GFP RNAi resulting in strong reduction of GFP expression.
The MYO-3::GFP abnormalities observed in the RNAi screen were grouped into three categories. (C) and (D) showing general disorganization of
myofilaments with minor aggregations, (E) and (F) exhibit well ordered and small aggregations (arrow) along otherwise well organized filaments, and
(G) and (H) large GFP clumps or deposits.
doi:10.1371/journal.pgen.1000537.g008
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S1). Six out of 22 genes did not result in a phenotype
distinguishable from wild type filament structure using this
approach and would therefore have been missed without the
sensitized background.
Together our two RNAi screens have identified 108 genes not
previously known to be involved in C. elegans muscle development
and/or function (Dataset S6). Only 15 of the 122 genes we
identified in our screens were previously characterized and shown
to be required for proper muscle function. Working from GO
annotation terms we have determined that several of these new
muscle-affecting genes fall into the categories of cell structure/
cellular processes, metabolism, gene expression, signal transduc-
tion, protein processing and protein-protein interactions. Several
of these newly identified muscle-affecting genes have no assigned
GO category and are, therefore, of completely unknown function.
Based on Ensembl annotations (http://ensembl.org), about 58%
of these new muscle-affecting genes encode proteins with sequence
similarity to human proteins (Dataset S6). In some cases protein
function can be inferred from the information known about the
human ortholog. However, that still leaves many genes without a
described function.
Discussion
In this study we have combined two large scale technologies,
transcriptional profiling using SAGE and gene inactivation using
RNAi, to identify novel genes involved in myofilament assembly
and/or stability. Our SAGE data identified 7,974 protein-coding
genes that are expressed in embryonic muscle cells, whereas a very
similar study using Affymetrix GeneChip technology identified
5,170 genes expressed in embryonic muscle [26]. In an attempt to
avoid sampling bias and low-level contamination by non-muscle
transcripts we chose to focus on genes identified by both
expression platforms; these would, presumably, have a higher
probability of being expressed in muscle cells. Our more limited
embryonic muscle transcriptome consists of ,3,500 genes, and we
used gene inactivation or knockdown by RNAi to determine the
function of some of these genes.
We generated two replicate long SAGE libraries for sorted
embryonic muscle cells, identifying 7,974 protein-coding genes,
including 64 previously described muscle affecting genes. More
than half of the genes identified by SAGE were not detected using
GeneChip technology, although the majority of these are
represented among the 22,150 transcripts represented on the
Affymetrix C. elegans genome array [26]. Conversely, about one
third of the genes detected by the GeneChip microarray are
missing form the SAGE libraries. Presumably a large portion of
this discrepancy is due to sampling and distinguishing signal from
noise. Consistent with previously published comparisons most of
the genes detected by SAGE but not detected by GeneChip
technology (,68%) have fewer than 5 sequence tags/library [40].
The total number of genes with only one sequence tag (singletons)
in either SW031, SWEM1 or both libraries accounts for 31.4% of
the total number of genes identified by SAGE analysis. In contrast,
less than 19% of the total number of genes identified by both
SAGE and GeneChips are singletons, 675 of the 2504 singletons
(27%) identified by SAGE are present in the Affymetrix GeneChip
study. In addition, we confirmed a number of singletons and genes
with low tag counts (,5) to be present in muscle cells by GFP
reporter studies. These data demonstrate that a not insignificant
number of genes are transcribed at very low levels in muscle and
one cannot simply ignore these low level transcripts if one wishes
to determine the full transcriptome of any specific tissue or cell
type. In future deep sequencing SAGE libraries may be the best
way to surmount the difficulty of gene expression across four
orders of magnitude. Low-level contamination will still be a
problem but at least detection will not be an issue.
As expected, many of the genes identified in embryonic muscle
also function in several types of cells. Comparing the data obtained
from the muscle, intestinal and pan neuronal libraries revealed
that between 11–16% of the genes identified in any one tissue are
specific to that tissue, although these estimates are possibly high.
Some of the genes in the muscle embryonic library are enriched in
muscle when compared to the other tissue specific libraries or the
whole embryo library. Generating SAGE library expression
profiles is useful for identifying candidate muscle genes for further
functional studies. We have identified 228 genes enriched 5-fold or
more in embryonic muscle cells compared to the whole embryo,
including known genes like mup-2 (troponin [49], 21.8-fold), unc-95
(LIM-domain containing protein [14], 7.7-fold), and mlc-2 (myosin
light chain [53], 14.3-fold) as well as many unknown or
uncharacterized genes (Dataset S2). Lowering the fold-change
cut-off to 1.7 reveals 1,459 muscle-enriched genes.
Our RNAi screens identified 108 new muscle-affecting genes.
Only four of these were identified in the first screen that
specifically looked for genes required for embryonic muscle
function. Many embryonic lethal mutants have been found in
various RNAi screens [43,54], but until now there has not been a
screen focused solely on identifying animals exhibiting the Pat
phenotype. In fact, two of the four genes found in our study
(F31D5.3 and T28B4.3) have not been reported to cause
embryonic lethality in any previous RNAi screens. Several genetic
studies have identified at least 19 loci that encode proteins essential
for muscle formation during early development (reviewed in [3]).
Most of these genetic loci, with the exception of pat-9 and pat-11,
have been identified at the sequence level and thus are correlated
with the physical map. Seventeen of the 19 known Pat genes were
included in our muscle transcriptome, and our screen identified
only eight of these. Given these results it would seem that RNAi
knockdown by feeding is not a very efficient method for identifying
Pat mutants. If this is the case, there are probably more ‘‘pat’’
genes to be discovered. Injection of double stranded RNA instead
of feeding has been used quite successfully by others [54,55] and
our preliminary RNAi knockdown treatments using this method
suggests that it is a much more effective, but also more time
consuming and expensive way to identify Pat mutants.
The majority of the new muscle-affecting genes that were
discovered were identified by specifically screening our refined
embryonic muscle transcriptome for disorganized myosin fila-
ments using a MYO-3::GFP marker strain, RW1596 [34]. The
only functional myosin heavy chain A (MYO-3) protein produced
in these animals is fused to GFP, a bulky, tubular protein
composed of 238 amino acids [33]. We have discovered that the
myofilaments in the body wall muscle of RW1596 hermaphrodites
are more sensitive to perturbation and the effects of aging than
those in the body wall muscle of wild type hermaphrodites.
Presumably, the barrel-shaped GFP reporter fused to MYO-3
prevents the tight packing of these molecules in the central bipolar
H zone of thick filaments. This would negatively affect the levels of
myosin heavy chain B (UNC-54) and paramyosin (UNC-15), as
well as prevent the proper assembly of these molecules into a
functional thick filament [56]. Thus, it is very likely that GFP-
tagging of the MYO-3 protein results in looser packing of the
myosin rods, thereby making the strain more sensitive to the
absence of auxiliary proteins resulting from RNAi treatment.
It should be noted that several genes previously shown to be
required for proper muscle assembly and maintenance were not
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animals with pat-3/ß-integrin dsRNA, despite having displayed
both sterility and uncoordinated movement, did not exhibit a
highly penetrant disorganized myofilament phenotype, and
therefore it was assigned to the LC class. There are several
possible explanations for not detecting previously described muscle
affecting genes, including the inherent variability in RNAi
screening, loss of the genomic insert in the bacterial clone, or
the means by which we screened animals for myofilament defects.
Validation of our approach was provided when we identified
several known muscle-affecting genes in the RNAi screens (Dataset
S6). For example, the UIG-1 protein was identified as a novel
dense body protein in a yeast two-hybrid screen for UNC-112
interacting proteins [57]. Although animals homozygous for the
uig-1(ok884) null mutation appear healthy and fertile, disorganiza-
tion of the body wall muscle filaments was observed in a polarized
light assay [57]. In our RNAi screen, as well as in previous RNAi
screens [43,54,58,59], knockdown of the uig-1 gene by RNAi
treatment did not result in any obvious morphological or growth
phenotypes. However, in the myofilament screen we were able to
detect MYO-3::GFP disorganization in 55% of scored animals
(n=63), resulting in an intermediate class phenotype, and this
phenotype correlates nicely with the earlier results [57]. The uig-1
gene is an example of a gene that affects muscle organization but
does not display a Pat or Unc phenotype. Such genes would be
difficult to identify in a high throughput screen without a reporter
gene for sarcomere integrity. In total, we identified 58 genes
without an obvious growth or anatomical phenotype when
inactivated by RNAi treatment, but which displayed an interme-
diate or high class phenotype when investigated for MYO-3::GFP
localization. While some of these genes may encode proteins
involved in muscle sarcomere assembly, we suspect most are
involved in accessory functions involved with sarcomere mainte-
nance and stability. Screening specifically for myofilament
abnormalities, therefore, has proven to be an effective way to
identify new genes affecting body wall muscle structure and
function.
The myofilament abnormalities we have observed in our screen
range from small aggregates to large deposits of GFP, which may
be within the filaments or adjacent to them. We also see gradients
of disorganization ranging from mild discontinuities in the
filaments to large interruptions often accompanied by the
accumulation of the MYO-3::GFP reporter protein. On occasion,
we also observed a marked decrease of MYO-3::GFP signal in the
myofilaments. These defects may be the result of several factors,
including abnormal or aberrant localization of MYO-3::GFP,
early onset sarcopenia, loss of myofilament stability and/or
defective myofilament assembly. With one exception (unc-112),
we assigned the 118 genes identified in our screen to different
categories based on the myofilament phenotype observed after
RNAi knockdown (Dataset S6). The first category represents the
least severe phenotype observed and includes the majority of the
genes identified, although only 4 of the 14 known muscle-affecting
genes were assigned to this category. This phenotype is consistent
with an early onset of the age related myofilament disorganization
that is seen in older RW1596 and wild type animals. However, our
current data do not allow to us to determine whether the
disorganization observed is due to defective myofilament assembly,
loss of myofilament stability or perhaps both. Two of the 4 known
genes in this category encode molecular chaperones and another
encodes a signaling molecule. The third category represents the
most severe phenotype observed and has the fewest assigned total
genes (14) but half of the known muscle affecting genes (7/14). The
majority of the known genes assigned to category three encode
structural components of dense bodies and/or M-lines or the
myofilaments, and most have been shown to be essential for the
assembly of the sarcomere during embryogenesis.
Annotation of our new candidate muscle-affecting genes using
ENSEMBL identified many different functions. Obviously, genes
encoding structural proteins or those with protein binding domains
are good candidates to be involved in sarcomere assembly and/or
stability, but predicted metabolic or signaling molecules can have a
structural function as well, as observed for pat-4, dim-1 and uig-1
[11,16,57]. We also identified seven genes involved in protein
turnover that appear to cause defects in sarcomere structure. It has
been shown previously that the degradation of UNC-45, a
molecular chaperone for myosin, by the E3/E4 complex formed
by CHN-1 and UFD-2 is indispensable for proper myosin folding
and assembly into thick filaments [60,61]. These newly identified
genes may be involved in comparable pathways.
Using integrated strategies like SAGE and RNAi provides an
initial step towards a comprehensive analysis of all the genes
required to form and maintain a muscle sarcomere in C. elegans.A
recent RNAi study from the laboratory of Norbert Perrimon using
Drosophila primary culture cells is, in principal, similar to our
study [62]. They identified 49 genes involved in late muscle
differentiation after examining 1,140 randomly chosen genes, and
22 of these genes were not previously known to be involved in
muscle function. Thirty-five of the 49 muscle-affecting genes
identified in the Drosophila RNAi study have a C. elegans ortholog.
However, only 16 of these met the SAGE and microarray criteria
of our study, and only 2, unc-15 and unc-112, were identified as
affecting myofilament organization. The remaining genes were
assigned to either the low class (9) or the wild type class (5). The
data obtained in these two studies reveals a significant number of
new players involved in muscle development. With the identifi-
cation of so many new protein involved in sarcomere formation
and maintenance perhaps we are nearing the time where some of




All strains were maintained using standard culture methods
[63]. The following strains were used: N2: wild-type Bristol isolate,
RW1596: myo-3(st386)V; stEx30 [34].
FACS analysis
GFP expressing muscle cells were isolated from freshly
dissociated RW1596 embryos as described previously [64] with
minor modifications. Embryos were treated with Chitinase (0.5
units) to dissolve the eggshell, concentrated by high-speed
centrifugation and then repeatedly passed through a 21-gauge
needle to dissociate the cells. The resulting cell suspension was
filtered through a 5 mm Millex-SV syringe filter, and pelleted by
gentle centrifugation. Isolated cells were resuspended in ice-cold
egg buffer and maintained on ice in preparation for the following
FACS procedure.
GFP expressing embryonic muscle cells were isolated using a
FACSVantage SE Diva cell sorter, equipped with a 488 nm Argon
laser and a 530615 nm emission filter for GFP, and a
585622 nm emission filter for propidium iodide (used to
discriminate dead cells). Non-GFP embryonic cells from wild type
N2 worms were used as controls to set instrument settings, and to
establish GFP sorting gates. Initially cells were analyzed for light
scatter properties such that a population of cells in a forward
scatter (cell size) vs. side scatter (granularity) plot was selected that
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in a GFP vs. PI plot to visualize GFP positive cells. The GFP
sorting gates were defined by comparing the profile of wild-type
embryonic cells with that of the MYO-3::GFP expressing cells.
Sorted cells were collected in 0.5 ml of egg buffer supplemented
with 5% FBS and immediately frozen in liquid nitrogen in
preparation for RNA isolation. An aliquot of cells from each sort
was cultured overnight on peanut lectin coated cover slips with L-
15 and 10% FBS as a culture medium. This overnight culture was
examined using fluorescent-light microscopy to gauge sort purity.
Library construction involved pooling RNA recovered from sorts
that were deemed to have a purity of $90%.
Production and analysis of the SAGE libraries
SAGE data for SWEM1, SW031, SWEG1, SW028, SWN22
were prepared by standard methods and analyzed as described
elsewhere [65,66]. All information is available at http://elegans.
bcgsc.ca/home/sage.html; Wormbase version WS180 (September
2007) was used for gene identification.
RNAi screen for essential muscle genes in liquid culture
The N2 strain was used for these experiments following the
protocol described previously [67]. RNAi clones were grown in
96-well plates overnight at 37uC in 150 ml of L-broth containing
50 mg/ml carbenicillin and 8% glycerol. The following morning,
10 ml of each freshly grown bacterial stock was transferred to 96-
well plates of Liquid NGM media (50 ml per well) containing
4 mM IPTG and 50 mg/ml carbenicillin. Liquid NGM plates
were incubated for 16 hours at 20uC and then 37uC for 2 hours.
Four synchronized L3 worms were then transferred into each well
using a Copas Biosorter-250 (Union Biometrica) and incubated at
20uC for 72 hours. Each well was scored for animals that exhibited
embryonic lethality, paralysis, or sterility. All RNAi treatments
that resulted in animals with the aforementioned phenotypes were
re-screened using solid NGM media. RNAi bacterial cultures were
grown overnight in 96-well plates containing 200 ml of L-broth
with 50 mg/ml carbenicillin. NGM plates containing 1 mM IPTG
and 50 mg/ml carbenicillin and were then streaked with the freshly
grown RNAi bacterial cultures and incubated at 20uC for
24 hours. Two L4 animals were then transferred to each plate,
and incubated for 72 hours at 20uC. Two F1 progeny at the L4
stage were then transferred to each of three replicate plates for
each RNAi treatment, and incubated at 20uC for 24 hours to lay
eggs. All of the plates were examined for animals exhibiting an
early embryonic arrest phenotype, a mixed stage embryonic arrest
phenotype, or a two-fold stage arrest phenotype.
RNAi screen for myofilament defects
The strains RW1596 and N2 wild-type was used for these
experiments following the protocol described previously [41].
RNAi colonies were grown overnight in L-broth with 50 mgm l
21
ampicillin and then streaked onto NGM plates containing 1 mM
IPTG and 50 mgm l
21 carbenicillin. The plates were incubated
overnight at room temperature to induce dsRNA expression.
Approximately 30 synchronized L1s (P0) animals were spotted
onto each RNAi plate. These plates were incubated at 20uC until
the worms reached the young adult stage (,60–68 hours), then 2
P0 were transferred onto fresh plates, in duplicate for each RNAi
clone. To synchronize the F1 generation, the adult animals were
removed after an 18-hour egg-laying period. Embryos were
allowed to hatch and develop to the L4/young adult stage
(,36 hours). Prior to the myofilament screen, animals were scored
for a variety of gross anatomical and growth defects such as
sterility, embryonic or larval lethality, uncoordinated movement,
and slow growth. Then, a random subset of worms (10–40) from
each duplicate plate were picked into 15 ml M9 buffer containing
10% sodium azide and their body wall muscle was screened for
MYO-3::GFP defects using a compound fluorescence microscope
(Zeiss Axiophot). An animal was scored positive when the majority
of muscle cells showed abnormal GFP fluorescence. Animals were
examined blind to the identity of the dsRNA. The empty vector
(L4440) was used as a negative control, and worms feeding on
bacteria expressing dsRNA for unc-97 or GFP were used as
positive controls on each day of screening. Digital photographs
were taken using a Qimaging QICAM digital camera running
Qcapture version 1.68.4.
For clones resulting in an embryonic lethal or sterile
phenotype in the first screen, the RNAi screening protocol
described above was modified as followed. The synchronized L1
worms were spotted onto empty vector (L4440) RNAi control
plates and then transferred to gene specific RNAi plates after
reaching the adult stage. The F1 generation was then examined
for myofilament defects as L4/young adults. All essays were
carried out at 20uC.
Database for myofilament screen
Images and observations for each gene screened were archived
in an online database, created using MySQL 3.23.49 with a web
interface written in PHP 4.3.4. Hosting was set up on a server
maintained by the Department of Zoology, University of British
Columbia (Canada).
Supporting Information
Figure S1 RNAi induced myofilament abnormalities visualized
by polarized light. (A) Myofilaments visualized by polarized light
microscopy in wild-type animals treated with the empty RNAi
feeding vector L4440 showing nicely organized filament structure
(arrows). In animals treated with dsRNA for F52A8.1 (B) and
H15N14.2 (C) filaments are disorganized and inconsistent
(asterisk). Filaments in animals treated with dsRNA for
T06A10.3 (D) are showing structural abnormalities at the cell-
cell boundaries (arrowheads).
Found at: doi:10.1371/journal.pgen.1000537.s001 (10.06 MB
TIF)
Dataset S1 Comparing muscle, intestinal, and pan neuronal
SAGE libraries.
Found at: doi:10.1371/journal.pgen.1000537.s002 (5.74 MB
XLS)
Dataset S2 SAGE tags comparing muscle versus embryo.
Found at: doi:10.1371/journal.pgen.1000537.s003 (5.93 MB
XLS)
Dataset S3 SAGE tags for known muscle affecting genes.
Found at: doi:10.1371/journal.pgen.1000537.s004 (0.10 MB
XLS)
Dataset S4 Comparison muscle SAGE and promoter::GFP
expression in muscle.
Found at: doi:10.1371/journal.pgen.1000537.s005 (1.06 MB
XLS)
Dataset S5 Comparing two methods, SAGE versus Affymetrix
GeneChip.
Found at: doi:10.1371/journal.pgen.1000537.s006 (5.22 MB
XLS)
Dataset S6 A comprehensive list of all genes identified in both
RNAi screens.
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